Inhibitor Therapeutics, Inc. (INTI) SEC Filings — 2025
5 SEC filings for Inhibitor Therapeutics, Inc. (INTI) in 2025.
Filings
- Inhibitor Therapeutics' Cash Dwindles Amid Rising R&D Costs — 10-Q · Nov 13, 2025
- Inhibitor Therapeutics: Director Departs, New Director Appointed — 8-K · Oct 27, 2025
- Inhibitor Therapeutics' Losses Widen Amid R&D Spend, Cash Dwindles — 10-Q · Aug 13, 2025
- Inhibitor Therapeutics Files Q1 2025 10-Q — 10-Q · May 14, 2025
- Inhibitor Therapeutics Files 2024 Annual Report — 10-K · Mar 28, 2025